CMB 1.41% 35.0¢ cambium bio limited

Ann: Regeneus to be granted new key Progenza patent in U.S., page-3

  1. 199 Posts.
    lightbulb Created with Sketch. 29
    Interesting how they managed to mention Corona in there.

    The patent to be granted for Progenza also covers Acute Respiratory Distress Syndrome
    (ARDS), an inflammatory lung condition identified as a cause of death among patients
    diagnosed with COVID-191

 
watchlist Created with Sketch. Add CMB (ASX) to my watchlist
(20min delay)
Last
35.0¢
Change
-0.005(1.41%)
Mkt cap ! $4.235M
Open High Low Value Volume
35.0¢ 35.5¢ 35.0¢ $52 148

Buyers (Bids)

No. Vol. Price($)
1 1328 35.0¢
 

Sellers (Offers)

Price($) Vol. No.
35.5¢ 261 1
View Market Depth
Last trade - 15.33pm 16/08/2024 (20 minute delay) ?
CMB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.